03839.HK
Chia Tai Enterprises International Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 8.69
−1.03%Year over year
Reported trailing growth
- Revenue
- -18.9%
- EBITDA
- -12.2%
- EBIT
- -7.2%
- EPS
- -6.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +49.9%
- EBITDA
- +110.6%
- EBIT
- +99.8%
- Net income
- +254.6%
- EPS
- +258.8%
- Free cash flow
- +1196.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026